TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Experts hold a mixed view on Manulife Financial (MFC), reflecting both cautious optimism and concerns over its growth prospects. Many analysts recognize the company's strong performance in Asian markets and wealth management, noting its potential for steady income through dividends, with several projecting double-digit growth. However, there are reservations regarding the current valuation, with some analysts suggesting a wait for market pullbacks before purchasing. Despite recent underperformance relative to peers and profit-taking activities, MFC is still viewed as a reliable long-term investment, especially for dividend-seeking investors. Concerns about broader market conditions and legacy business challenges persist, but the company's fundamentals appear solid.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Jun 09/22, Down 8.5%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MFC has triggered its stop at $21.50. To remain disciplined, we recommend covering the position at this time. This will result in a next investment loss of 10%, when combined with previous buy recommendations.
PAST TOP PICK
(A Top Pick Jun 03/21, Down 9%) Asia is promising. Sluggish GDP in Canada is holding it back, as well as prior management decisions. Looks perennially cheap, but the stock can't seem to get out of its own way.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly As one of Canada's largest financial and insurance providers, we again reiterate MFC as a TOP PICK. Recently reported earnings missed expectations, due to higher than expected mortality rates in the US due to COVID. However, moving forward the company recently de-risked a sizable portion of their US annuity business that frees up over $2 billion in capital. Higher interest rates will also benefit the company. It trades at only 5x earnings, supports a ROE over 18% and is valued just under book. It pays a healthy dividend, backed by a payout ratio under 30%. We continue to recommend a stop loss at $21.50, looking to achieve $28 -- upside potential over 18%. Yield 5.6% (Analysts’ price target is $27.67)
BUY
Insurance companies usually benefit from rising rates. Global company. Financials are attractive, as he expects the yield curve to normalize over the next year or two.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly With a market cap of $50 billion, MFC is one of Canada's largest financial services firms. It is in a space that tends to benefit from rising interest rates and we reiterate it as TOP PICK. It trades right at book value and at 7x earnings, it is good value here. The dividend was recently bumped up over 17% and is backed by a payout ratio under 35% of cash flow. We are recommend to slide the stop (down from $24.50) to $21.50, to accommodate current market uncertainty, looking to achieve $30 -- upside potential over 20%. Yield 5.19% (Analysts’ price target is $30.00)
DON'T BUY
They take on too much risk and the dividend doesn't make him buy.
PAST TOP PICK
(A Top Pick Apr 21/21, Down 1%) At close to book value, better priced today than SLF, which also has a lower yield. Large exposure to Asia's continuing Covid situation may explain lagging performance. Extremely well structured and financed. No hesitation in recommending it long term. Yield slightly over 5%.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly As one of Canada's largest insurers, with rapidly growing operations in the US and Asia, we again reiterate MFC as a TOP PICK. Recently reported earnings again beat analyst expectations and support a respectable 14% ROE, which helps support a great dividend yield that employs less than 35% of cash flow. It trades at 8x earnings, compared to peers at 33x. We recommend trailing up the stop (from $21.00) to $24.50, looking to achieve 31.50 -- 15% upside potential. Yield 4.84% (Analysts’ price target is $31.33)
BUY
Great Asian franchise. Asset management business has been tough, decreasing margins. Will continue to do better, especially as we see less volatility. Worth owning here. Nice yield of almost 5%, not trading at a huge multiple at 1.2x book.
WEAK BUY
A pocket of value in the sector, life insurance is the cheapest in the group. Lifecos definitely have room for multiple expansion and earnings growth. His preferred name is GWO, with a more mature M&A market focus. MFC is more focused on EM.
DON'T BUY
It's so tough here. He ranks it negatively. The financial health of MFC is poor. If it breaks below $25.43, watch out. It yield 4.9%, but he is worried about financials trading at these levels. There's something wrong with their balance sheet, but he hasn't done a deep dive on it. Sell if it falls to $24.50. Doesn't see an upside here, just the dividend.
PARTIAL SELL
A stellar performance in the last 6 months with strong dividend growth in the past year. But slower economic activity in Asia is a headwind. Take profits or sell, then re-enter in the summer on a 10-15% pullback. He likes the dividend.
COMMENT
Hasn't been a growth story. When an insurance company writes an insurance policy, they have a long term liability. They need to earn a rate of return. 5-6 years, there hasn't been growth. Likes it and owns it below $20-$25. Does not want to own it around $30.
BUY ON WEAKNESS
Defensive, modest beats, clean last quarter, doing well in Asia, incredibly cheap, decent growth rate. Sort of like that cough syrup commercial, "You might not like it, but it works." Has severely underperformed. Accounting standards headwinds. Trades at 6x with a 10% growth rate. Whippy stock, you can probably purchase under $25 or 24.50.
SELL ON STRENGTH
Allan Tong’s Discover Picks MFC pays a safe dividend, too (at a 32.98% payout ratio), but it’s even higher at 5.16%. Mind you, the street has a bullish forward PE of 11.91x on SLF, so the street believes in the company’s growth. Profit margins of both insurers are virtually the same around 11.5%, but MFC trades at a lower PE of 7.3x. However, MFC shares can never breach $28, despite consistent price targets as high as $30. Why, I don’t know, but the charts are there to see. Read 4 Promising TSX Stocks for our full analysis.
Showing 181 to 195 of 2,281 entries